Transportability and generalizability analysis are novel causal inference methods that quantitatively assess external validity. Currently, it is unclear how these analyses are applied in practice. To characterize applications and methods, we conducted a landscape analysis of applied transportability and generalizability analyses using a systematic literature search of PubMed, CINAHL and Embase supplemented with hand-searches. We identified 68 publications describing transportability and generalizability analyses conducted with 83 unique source-target dataset pairs and reporting 99 distinct analyses. The majority of source and target datasets were collected in the US (n=63/83, 75.9%; and n=59/83, 71.1%, respectively). These methods were most often applied to transport RCT findings to observational studies (n=38/83; 45.8%), or to another RCT (n=20/83; 24.1%). Several studies used transportability analysis outside the standard application, for example to identify effect modifiers or calibrate measurements within an RCT. Methods that used weights and individual-level patient data were most common (n=56/99, 56.5%; n=80/83, 96.4%, respectively). Reporting quality varied across studies. Transportability analysis has a wide range of applications including supporting decision-making by improving evidence relevance and improving trial design by identifying contextual effect modifiers and calibrating outcome measurements. Efforts are needed to standardize analysis and reporting of these methods to improve transparency and uptake.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.annepidem.2025.03.001 | DOI Listing |
Ann Epidemiol
March 2025
Core Clinical Sciences, 401-34 W. 7(th) Ave., Vancouver, BC, V5Y 1L6 Canada; Department of Health Research Methods, Evidence, and Impact, McMaster University, 1280 Main Street West, Hamilton, ON, L8S 4L8 Canada. Electronic address:
Transportability and generalizability analysis are novel causal inference methods that quantitatively assess external validity. Currently, it is unclear how these analyses are applied in practice. To characterize applications and methods, we conducted a landscape analysis of applied transportability and generalizability analyses using a systematic literature search of PubMed, CINAHL and Embase supplemented with hand-searches.
View Article and Find Full Text PDFAlzheimers Dement
March 2025
Bordeaux Population Health Center, INSERM, UMR U1219, University of Bordeaux, Bordeaux, France.
Introduction: An integrative polygenic risk score (iPRS) capturing the neurodegenerative and vascular contribution to dementia could identify high-risk individuals and improve risk prediction.
Methods: We developed an iPRS for dementia (iPRS-DEM) in Europeans (aged 65+), comprising genetic risk for Alzheimer's disease (AD) and 23 vascular or neurodegenerative traits (excluding apolipoprotein E [APOE]). iPRS-DEM was evaluated across cohorts comprising older community-dwelling people (N = 3702), a multi-ancestry biobank (N = 130,797 Europeans; 105,404 non-Europeans), and dementia-free memory clinic participants (N = 2032).
J Clin Epidemiol
February 2025
Department of Clinical Epidemiology, McGill University, Montreal, Quebec, Canada.
Objectives: While subgroup analyses are common in epidemiologic research, restriction to subgroup members can yield imprecise estimates. We aimed to demonstrate how methods extending inferences to external targets improve precision of subgroup estimates under the major assumption effects differ between subgroup members and nonmembers due to measured effect measure modifiers (EMMs) and membership is independent of the effect after conditioning on EMMs.
Study Design And Setting: We applied this approach in the Panitumumab Randomized Trial in Combination with Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy.
NPJ Digit Med
February 2025
Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Pivotal moments in sepsis care occur in the emergency department (ED), however, and it is unclear whether ED data is adequate to inform reinforcement learning (RL) models. We evaluated the early opportunity for the AI Clinician, a validated ICU-based RL-model, as a use case. Amongst emergency sepsis patients, model parameters were often missing and invariably measured.
View Article and Find Full Text PDFJ Am Med Inform Assoc
March 2025
Department of Health Policy, Stanford School of Medicine, Stanford, CA 94305, United States.
Objectives: The inclusion of social drivers of health (SDOH) into predictive algorithms of health outcomes has potential for improving algorithm interpretation, performance, generalizability, and transportability. However, there are limitations in the availability, understanding, and quality of SDOH variables, as well as a lack of guidance on how to incorporate them into algorithms when appropriate to do so. As such, few published algorithms include SDOH, and there is substantial methodological variability among those that do.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!